Coramaze Technologies Israeli Company
Coramaze Technologies develops the Tripair, a simple, rapid, and effective percutaneous treatment for tricuspid valve disease. The treatment is intended to improve quality of life and reduce morbidity for heart failure patients suffering from tricuspid regurgitation.
Health Tech & Life Sciences
Health Care
Medical
Medical Device
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
Office Locations
Petah Tikva, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/coramaze
[2]
crunchbase.com
- https://www.crunchbase.com/organization/coramaze-technologies
External links are provided for reference and verification purposes.